Edurant

NOTICE: This Consumer Medicine Information (CMI) is intended for persons

Cresemba

NOTICE: This Consumer Medicine Information (CMI) is intended for persons

Methoblastin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons

APO-Itraconazole

NOTICE: This Consumer Medicine Information (CMI) is intended for persons

Rapamune Tablets

NOTICE: This Consumer Medicine Information (CMI) is intended for persons

Simponi

NOTICE: This Consumer Medicine Information (CMI) is intended for persons

Gene editing enables researchers to correct mutation in muscle stem cells in DMD model: Correction of mutation in muscle stem cells with CRISPR editing may pave the way for lifelong treatments for muscular dystrophy

Duchenne muscular dystrophy (DMD) is a rare but devastating genetic